Senior Peer Alliance for Rural Research On Wellness
SPARROW
Case Management and Problem Solving Therapy for Depressed Older Adults
1 other identifier
interventional
105
1 country
1
Brief Summary
Dr. Brooke Hollister, Ph.D. from the department of Social and Behavioral Sciences at the University of California, San Francisco is conducting a study comparing two types of interventions for treating depression in rural older adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2013
CompletedFirst Posted
Study publicly available on registry
August 1, 2013
CompletedStudy Start
First participant enrolled
August 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2019
CompletedJuly 31, 2019
July 1, 2019
5 years
July 29, 2013
July 30, 2019
Conditions
Outcome Measures
Primary Outcomes (8)
Hamilton Rating Scale for Depression (HRSD)
A multiple item questionnaire used to provide an indication of depression, and as a guide to evaluate recovery.
Baseline
Hamilton Rating Scale for Depression (HRSD)
A multiple item questionnaire used to provide an indication of depression, and as a guide to evaluate recovery.
Week 3
Hamilton Rating Scale for Depression (HRSD)
A multiple item questionnaire used to provide an indication of depression, and as a guide to evaluate recovery.
Week 6
Hamilton Rating Scale for Depression (HRSD)
A multiple item questionnaire used to provide an indication of depression, and as a guide to evaluate recovery.
Week 12
WHO Disability Assessment Schedule 2.0 (WHODAS-II)
Generic assessment instrument for health and disability
Week 0
WHO Disability Assessment Schedule 2.0 (WHODAS-II)
Generic assessment instrument for health and disability
Week 3
WHO Disability Assessment Schedule 2.0 (WHODAS-II)
Generic assessment instrument for health and disability
Week 6
WHO Disability Assessment Schedule 2.0 (WHODAS-II)
Generic assessment instrument for health and disability
Week 12
Study Arms (2)
CM-PST
EXPERIMENTALIf you are assigned to CM-PST, you will be working with the same care manager from your introductory session. The care manager will continue to work with you on your problem-solving plan. Additionally, you will receive case management services.
SG-PST
EXPERIMENTALIf you are assigned to SG-PST, you will continue to work on your problem-solving plan, using the self-guided materials provided to you during the introductory session. Additionally, you will be partnered with a senior peer counselor who will support you in your SG-PST efforts.
Interventions
Eligibility Criteria
You may qualify if:
- Residence in rural Tuolumne, Calaveras, San Joaquin or Stanislaus Counties;
- Diagnosis: Major depression, unipolar (by SCID ascertained DSM-IV criteria);
- Severity of depression: A PHQ-9\>10 or a 24-Item HDRS\>19;
- Need for social services: CANE score\> 2, i.e. at least one unmet need;
You may not qualify if:
- Psychotic depression by SCID-IV, i.e., presence of delusions;
- High suicide risk, i.e. intent or plan to attempt suicide in near future;
- Presence of any Axis I psychiatric disorder or substance abuse other than unipolar major depression;
- Axis II diagnosis of antisocial personality (by SCID-P and DSM-IV);
- History of psychiatric disorders other than unipolar major depression or generalized anxiety disorder (including bipolar disorder, hypomania, and dysthymia);
- Dementia: MMSE below 24 or clinical diagnosis of dementia by DSM-IV;
- Acute/severe medical illness (delirium, metastatic cancer, de-compensated cardiac, liver or kidney failure, stroke or myocardial infarction) 3 months prior to entry; or use of drugs causing depression, (steroids, reserpine, alphamethyl-dopa, tamoxiphen, vincristine);
- Inability to speak English;
- Aphasia interfering with communication;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Catholic Charities Motherlode Office- Sonora
Sonora, California, 95370, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Brooke Hollister, Ph.D.
University of California, San Francisco
- PRINCIPAL INVESTIGATOR
Patricia Arean, Ph.D.
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2013
First Posted
August 1, 2013
Study Start
August 1, 2013
Primary Completion
August 1, 2018
Study Completion
March 31, 2019
Last Updated
July 31, 2019
Record last verified: 2019-07